pubmed-article:16647870 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16647870 | lifeskim:mentions | umls-concept:C0029408 | lld:lifeskim |
pubmed-article:16647870 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16647870 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:16647870 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
pubmed-article:16647870 | lifeskim:mentions | umls-concept:C0008466 | lld:lifeskim |
pubmed-article:16647870 | lifeskim:mentions | umls-concept:C0017718 | lld:lifeskim |
pubmed-article:16647870 | lifeskim:mentions | umls-concept:C1516048 | lld:lifeskim |
pubmed-article:16647870 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:16647870 | pubmed:dateCreated | 2007-6-12 | lld:pubmed |
pubmed-article:16647870 | pubmed:abstractText | Thirty-five dogs were included in a randomised, double-blind, positive controlled, multi-centre trial to assess the efficacy of an orally-administered glucosamine hydrochloride and chondroitin sulfate (Glu/CS) combination for the treatment of confirmed osteoarthritis of hips or elbows. Carprofen was used as a positive control. Dogs were re-examined on days 14, 42 and 70 after initiation of treatment. Medication was then withdrawn and dogs were re-assessed on day 98. Response to treatment was based on subjective evaluation by participating veterinarians who recorded their findings at each visit. Dogs treated with Glu/CS showed statistically significant improvements in scores for pain, weight-bearing and severity of the condition by day 70 (P<0.001). Onset of significant response was slower for Glu/CS than for carprofen-treated dogs. The results show that Glu/CS has a positive clinical effect in dogs with osteoarthritis. | lld:pubmed |
pubmed-article:16647870 | pubmed:language | eng | lld:pubmed |
pubmed-article:16647870 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16647870 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16647870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16647870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16647870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16647870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16647870 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16647870 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16647870 | pubmed:month | Jul | lld:pubmed |
pubmed-article:16647870 | pubmed:issn | 1090-0233 | lld:pubmed |
pubmed-article:16647870 | pubmed:author | pubmed-author:MooneyCarmelC | lld:pubmed |
pubmed-article:16647870 | pubmed:author | pubmed-author:McAllisterHes... | lld:pubmed |
pubmed-article:16647870 | pubmed:author | pubmed-author:JonesBoydB | lld:pubmed |
pubmed-article:16647870 | pubmed:author | pubmed-author:McCarthyGrain... | lld:pubmed |
pubmed-article:16647870 | pubmed:author | pubmed-author:O'DonovanJame... | lld:pubmed |
pubmed-article:16647870 | pubmed:author | pubmed-author:SeedMichaelM | lld:pubmed |
pubmed-article:16647870 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16647870 | pubmed:volume | 174 | lld:pubmed |
pubmed-article:16647870 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16647870 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16647870 | pubmed:pagination | 54-61 | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:meshHeading | pubmed-meshheading:16647870... | lld:pubmed |
pubmed-article:16647870 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:16647870 | pubmed:articleTitle | Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. | lld:pubmed |
pubmed-article:16647870 | pubmed:affiliation | Department of Small Animal Clinical Studies, School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, UCD Dublin, Belfield, Dublin 4, Ireland. grainne.mccarthy@ucd.ie | lld:pubmed |
pubmed-article:16647870 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16647870 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16647870 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16647870 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16647870 | lld:pubmed |